Logo image of OPAD

OFFERPAD SOLUTIONS INC (OPAD) Stock Fundamental Analysis

NYSE:OPAD - New York Stock Exchange, Inc. - US67623L3078 - Common Stock - Currency: USD

2.24  -0.03 (-1.32%)

After market: 2.24 0 (0%)

Fundamental Rating

1

OPAD gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 63 industry peers in the Real Estate Management & Development industry. Both the profitability and financial health of OPAD have multiple concerns. OPAD does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

OPAD had negative earnings in the past year.
OPAD had a negative operating cash flow in the past year.
OPAD Yearly Net Income VS EBIT VS OCF VS FCFOPAD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 200M -200M -400M -600M -800M

1.2 Ratios

OPAD has a worse Return On Assets (-17.81%) than 76.67% of its industry peers.
OPAD has a Return On Equity of -93.14%. This is amonst the worse of the industry: OPAD underperforms 81.67% of its industry peers.
Industry RankSector Rank
ROA -17.81%
ROE -93.14%
ROIC N/A
ROA(3y)-16.13%
ROA(5y)N/A
ROE(3y)-78.18%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OPAD Yearly ROA, ROE, ROICOPAD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 -20 -40 -60 -80 -100

1.3 Margins

Looking at the Gross Margin, with a value of 7.95%, OPAD is doing worse than 78.33% of the companies in the same industry.
OPAD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 7.95%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OPAD Yearly Profit, Operating, Gross MarginsOPAD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 5 -5 10

More info and screens

1

2. Health

2.1 Basic Checks

OPAD does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for OPAD has been reduced compared to 1 year ago.
The debt/assets ratio for OPAD has been reduced compared to a year ago.
OPAD Yearly Shares OutstandingOPAD Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 10M 20M 30M
OPAD Yearly Total Debt VS Total AssetsOPAD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.2 Solvency

OPAD has an Altman-Z score of 1.00. This is a bad value and indicates that OPAD is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.00, OPAD is doing worse than 60.00% of the companies in the same industry.
OPAD has a Debt/Equity ratio of 3.88. This is a high value indicating a heavy dependency on external financing.
OPAD has a worse Debt to Equity ratio (3.88) than 88.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.88
Debt/FCF N/A
Altman-Z 1
ROIC/WACCN/A
WACC5.62%
OPAD Yearly LT Debt VS Equity VS FCFOPAD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 200M -200M -400M -600M -800M

2.3 Liquidity

OPAD has a Current Ratio of 1.23. This is a normal value and indicates that OPAD is financially healthy and should not expect problems in meeting its short term obligations.
OPAD has a worse Current ratio (1.23) than 60.00% of its industry peers.
A Quick Ratio of 0.25 indicates that OPAD may have some problems paying its short term obligations.
OPAD has a worse Quick ratio (0.25) than 91.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 0.25
OPAD Yearly Current Assets VS Current LiabilitesOPAD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 200M 400M 600M 800M 1B

More info and screens

3

3. Growth

3.1 Past

OPAD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 80.79%, which is quite impressive.
Looking at the last year, OPAD shows a very negative growth in Revenue. The Revenue has decreased by -43.75% in the last year.
EPS 1Y (TTM)80.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%32.88%
Revenue 1Y (TTM)-43.75%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-11.17%

3.2 Future

Based on estimates for the next years, OPAD will show a very strong growth in Earnings Per Share. The EPS will grow by 20.73% on average per year.
The Revenue is expected to grow by 8.19% on average over the next years. This is quite good.
EPS Next Y53.7%
EPS Next 2Y32.47%
EPS Next 3Y21.89%
EPS Next 5Y20.73%
Revenue Next Year-30.74%
Revenue Next 2Y-2.77%
Revenue Next 3Y5.51%
Revenue Next 5Y8.19%

3.3 Evolution

OPAD Yearly Revenue VS EstimatesOPAD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B
OPAD Yearly EPS VS EstimatesOPAD Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -2 -4 -6 -8 -10

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for OPAD. In the last year negative earnings were reported.
Also next year OPAD is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OPAD Price Earnings VS Forward Price EarningsOPAD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OPAD Per share dataOPAD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

OPAD's earnings are expected to grow with 21.89% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.47%
EPS Next 3Y21.89%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for OPAD!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OFFERPAD SOLUTIONS INC

NYSE:OPAD (2/21/2025, 8:04:01 PM)

After market: 2.24 0 (0%)

2.24

-0.03 (-1.32%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)11-04 2024-11-04/amc
Earnings (Next)02-24 2025-02-24/amc
Inst Owners63.78%
Inst Owner Change-99.56%
Ins Owners18.94%
Ins Owner Change0.01%
Market Cap61.31M
Analysts74.55
Price Target3.86 (72.32%)
Short Float %4.33%
Short Ratio18.06
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-19.09%
Min EPS beat(2)-29%
Max EPS beat(2)-9.18%
EPS beat(4)0
Avg EPS beat(4)-23.34%
Min EPS beat(4)-35.67%
Max EPS beat(4)-9.18%
EPS beat(8)2
Avg EPS beat(8)-14.96%
EPS beat(12)4
Avg EPS beat(12)-4.57%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-6.74%
Min Revenue beat(2)-13.18%
Max Revenue beat(2)-0.3%
Revenue beat(4)1
Avg Revenue beat(4)-3.88%
Min Revenue beat(4)-13.18%
Max Revenue beat(4)3.54%
Revenue beat(8)4
Avg Revenue beat(8)5.39%
Revenue beat(12)7
Avg Revenue beat(12)6.97%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.19%
PT rev (3m)-3.19%
EPS NQ rev (1m)0.52%
EPS NQ rev (3m)0.52%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-0.2%
Revenue NQ rev (3m)-0.2%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)-0.04%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.06
P/FCF N/A
P/OCF N/A
P/B 0.95
P/tB 0.95
EV/EBITDA N/A
EPS(TTM)-2.2
EYN/A
EPS(NY)-1.14
Fwd EYN/A
FCF(TTM)-1.06
FCFYN/A
OCF(TTM)-1.01
OCFYN/A
SpS35.99
BVpS2.36
TBVpS2.36
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.81%
ROE -93.14%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 7.95%
FCFM N/A
ROA(3y)-16.13%
ROA(5y)N/A
ROE(3y)-78.18%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover2.91
Health
Industry RankSector Rank
Debt/Equity 3.88
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 214.87%
Cap/Sales 0.13%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.23
Quick Ratio 0.25
Altman-Z 1
F-Score5
WACC5.62%
ROIC/WACCN/A
Cap/Depr(3y)955.82%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.23%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)80.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%32.88%
EPS Next Y53.7%
EPS Next 2Y32.47%
EPS Next 3Y21.89%
EPS Next 5Y20.73%
Revenue 1Y (TTM)-43.75%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-11.17%
Revenue Next Year-30.74%
Revenue Next 2Y-2.77%
Revenue Next 3Y5.51%
Revenue Next 5Y8.19%
EBIT growth 1Y72.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year75.69%
EBIT Next 3Y29.43%
EBIT Next 5Y16.67%
FCF growth 1Y90.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y91.01%
OCF growth 3YN/A
OCF growth 5YN/A